fusidic acid has been researched along with dicloxacillin in 12 studies
| Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (dicloxacillin) | Trials (dicloxacillin) | Recent Studies (post-2010) (dicloxacillin) |
|---|---|---|---|---|---|
| 1,742 | 117 | 344 | 628 | 55 | 58 |
| Protein | Taxonomy | fusidic acid (IC50) | dicloxacillin (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Faber, M; Høiby, N; Jensen, T; Koch, C; Lanng, S; Rosdahl, VT | 1 |
| Arevalo López, A; Durán Bermúdez, H; Kuri Con, FJ; Macotela-Ruiz, E; Villalobos Ibarra, JL | 1 |
| Fomina, IP; Kuznetsova, SM; Speranskaia, ON | 1 |
| Archer, G; Bornholm, J; Yu, VL; Zuravleff, JJ | 1 |
| Høiby, N; Szaff, M | 1 |
| Byron, MP; Carruth, WA; Hampton, AA; Sherertz, RJ; Solomon, DD | 1 |
| Black, FT; Nielsen, SL | 2 |
| Lanier, J; Qui, MK; Shim, J | 1 |
1 review(s) available for fusidic acid and dicloxacillin
| Article | Year |
|---|---|
Clinical inquiry: what is the best treatment for impetigo ?
Topics: Administration, Topical; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacitracin; Bridged Bicyclo Compounds, Heterocyclic; Cephalexin; Clindamycin; Cloxacillin; Dicloxacillin; Diterpenes; Erythromycin; Fusidic Acid; Gentamicins; Humans; Impetigo; Meta-Analysis as Topic; Mupirocin; Randomized Controlled Trials as Topic | 2014 |
1 trial(s) available for fusidic acid and dicloxacillin
| Article | Year |
|---|---|
[Evaluation of the efficacy and toxicity of local fusidic aid versus oral dicloxacillin in infections of the skin].
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Dicloxacillin; Female; Fusidic Acid; Humans; Male; Skin Diseases, Infectious; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes | 1988 |
10 other study(ies) available for fusidic acid and dicloxacillin
| Article | Year |
|---|---|
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Clinical experiences with fusidic acid in cystic fibrosis patients.
Topics: Bacteriophage Typing; Cystic Fibrosis; Denmark; Dicloxacillin; Fusidic Acid; Humans; Immunoelectrophoresis; Lung Diseases; Microbial Sensitivity Tests; Precipitin Tests; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus | 1990 |
[Methicillin-resistant staphylococci: biological properties and sensitivity to antibiotics].
Topics: Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephaloridine; Chloramphenicol; Dicloxacillin; Erythromycin; Fusidic Acid; Gentamicins; Kanamycin; Methicillin; Oxacillin; Penicillin G; Penicillin Resistance; Penicillinase; Rifampin; Staphylococcus; Streptomycin; Tetracycline; Vancomycin | 1973 |
In-vitro synergy testing of triple antibiotic combinations against Staphylococcus epidermidis isolates from patients with endocarditis.
Topics: Anti-Bacterial Agents; Dicloxacillin; Drug Combinations; Drug Synergism; Endocarditis, Bacterial; Fusidic Acid; Gentamicins; Humans; Microbial Sensitivity Tests; Rifampin; Staphylococcus epidermidis; Vancomycin | 1984 |
Antibiotic treatment of Staphylococcus aureus infection in cystic fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Cystic Fibrosis; Dicloxacillin; Female; Fusidic Acid; Humans; Infant; Male; Oxacillin; Probenecid; Pseudomonas Infections; Rifampin; Staphylococcal Infections | 1982 |
Efficacy of antibiotic-coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits.
Topics: Animals; Anti-Bacterial Agents; Catheterization; Catheters, Indwelling; Chlorhexidine; Ciprofloxacin; Clindamycin; Dicloxacillin; Fusidic Acid; Half-Life; Rabbits; Staphylococcal Infections | 1993 |
The effect of dicloxacillin and fusidic acid on the extracellular and intracellular killing of Staphylococcus aureus.
Topics: Adult; Anti-Bacterial Agents; Colony Count, Microbial; Dicloxacillin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fusidic Acid; Granulocytes; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Staphylococcus aureus; Superoxides | 1998 |
Extracellular and intracellular killing in neutrophil granulocytes of Staphylococcus aureus with rifampicin in combination with dicloxacillin or fusidic acid.
Topics: Adult; Dicloxacillin; Drug Therapy, Combination; Fusidic Acid; Humans; Microbial Sensitivity Tests; Neutrophils; Rifampin; Staphylococcus aureus | 1999 |